Live Breaking News & Updates on மொட்டி பார்பிசிதஎன்

Stay updated with breaking news from மொட்டி பார்பிசிதஎன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Can-Fite Expands its Phase II COVID-19 Study to Europe


Press release content from Business Wire. The AP news staff was not involved in its creation.
Can-Fite Expands its Phase II COVID-19 Study to Europe
April 22, 2021 GMT
PETACH TIKVA, Israel (BUSINESS WIRE) Apr 22, 2021
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced the expansion of its Phase II COVID-19 study of Piclidenoson to two European countries, Romania and Bulgaria.
The randomized, double blind, placebo-controlled study is evaluating the benefits of treatment of Piclidenoson plus standard supportive care (SSC) vs. placebo plus SSC in patients hospitalized with moderate to severe COVID-19, as defined by the U.S. National Institutes of Health Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Patients are randomized in a 1:1 ratio to receive 2 mg Piclidenoson twice daily or placebo, and tr ....

United States , Fite Biopharma , Motti Farbstein , Pnina Fishman , Exchange Commission , Fite Biopharma Ltd , Drug Administration , Health Coronavirus Disease , Orphan Drug Designation , Fast Track Designation , Can Fite Biopharma Ltd , Business Wire , ஒன்றுபட்டது மாநிலங்களில் , மொட்டி பார்பிசிதஎன் , ப்ணிந மீன் , பரிமாற்றம் தரகு , ஆர்ஃபந் மருந்து பதவி , வேகமாக டிராக் பதவி , வணிக கம்பி ,